Analysis of PI3K pathway components in human cancers

Area of Science:

• Oncology
• Molecular Biology
• Genomics

Background:

• Tumorigenesis involves complex molecular pathways, including the phosphoinositide 3-kinase (PI3K)/AKT pathway.
• Abundant data in cancer research necessitates focused investigation of key signaling proteins.
• The PI3K/AKT pathway is crucial for cancer cell growth and progression.

Purpose of the Study:

• To investigate the expression patterns of 25 proteins involved in PI3K pathway activation in 20 distinct cancer types.
• To identify potential therapeutic targets based on differential protein expression in tumors.
• To gain insights into the molecular underpinnings of various cancers.

Main Methods:

• Utilized data from the Human Protein Atlas database.
• Analyzed the expression of 25 pre-selected PI3K pathway-associated proteins.
• Compared protein expression across 20 different cancer types.

Main Results:

• Identified pronounced expression of specific proteins within distinct cancer tissues.
• Observed varied expression profiles for proteins such as AKTIP, BAD, GSK3B, PIK3CA, PTEN, RHEB, RPS6KB1, TSC1, TP53, BCL2, CCND1, CREBBP, PTK2, and EGFR.
• Highlighted potential biomarkers for specific cancers based on protein expression levels.

Conclusions:

• Specific protein expression patterns in cancer tissues may serve as valuable therapeutic targets.
• The study provides insights into the molecular basis of cancer progression.
• Targeted analysis of PI3K pathway proteins can inform novel cancer treatment strategies.